Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1995-4-24
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0070-217X
pubmed:author
pubmed:issnType
Print
pubmed:volume
194
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
145-54
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7534666-Adult, pubmed-meshheading:7534666-Antigens, Viral, pubmed-meshheading:7534666-Azacitidine, pubmed-meshheading:7534666-Base Sequence, pubmed-meshheading:7534666-Burkitt Lymphoma, pubmed-meshheading:7534666-DNA, Neoplasm, pubmed-meshheading:7534666-DNA, Viral, pubmed-meshheading:7534666-DNA-Binding Proteins, pubmed-meshheading:7534666-Epstein-Barr Virus Nuclear Antigens, pubmed-meshheading:7534666-Gene Expression Regulation, Viral, pubmed-meshheading:7534666-Herpesviridae Infections, pubmed-meshheading:7534666-Herpesvirus 4, Human, pubmed-meshheading:7534666-Humans, pubmed-meshheading:7534666-Immunodominant Epitopes, pubmed-meshheading:7534666-Lymphoma, B-Cell, pubmed-meshheading:7534666-Methylation, pubmed-meshheading:7534666-Molecular Sequence Data, pubmed-meshheading:7534666-Polymerase Chain Reaction, pubmed-meshheading:7534666-Tumor Cells, Cultured, pubmed-meshheading:7534666-Tumor Virus Infections, pubmed-meshheading:7534666-Viral Matrix Proteins, pubmed-meshheading:7534666-Virus Activation
pubmed:year
1995
pubmed:articleTitle
Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies.
pubmed:affiliation
Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.